In focus · trending topic

oncology

319 stories · following the connections

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

George O. Elston Named Chief Executive Officer of 2X Oncology

By Nasdaq OMXMay 30, 2017, 4:26 PM UTC

George O. Elston Named Chief Executive Officer of 2X Oncology

By Nasdaq OMXMay 30, 2017, 4:26 PM UTC

GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform

By Nasdaq OMXMay 30, 2017, 11:03 AM UTC